Literature DB >> 26455469

Rho kinase is required to prevent retinal axons from entering the contralateral optic nerve.

Paula B Cechmanek1, Carrie L Hehr1, Sarah McFarlane2.   

Abstract

To grow out to contact target neurons an axon uses its distal tip, the growth cone, as a sensor of molecular cues that help the axon make appropriate guidance decisions at a series of choice points along the journey. In the developing visual system, the axons of the output cells of the retina, the retinal ganglion cells (RGCs), cross the brain midline at the optic chiasm. Shortly after, they grow past the brain entry point of the optic nerve arising from the contralateral eye, and extend dorso-caudally through the diencephalon towards their optic tectum target. Using the developing visual system of the experimentally amenable model Xenopus laevis, we find that RGC axons are normally prevented from entering the contralateral optic nerve. This mechanism requires the activity of a Rho-associated kinase, Rock, known to function downstream of a number of receptors that recognize cues that guide axons. Pharmacological inhibition of Rock in an in vivo brain preparation causes mis-entry of many RGC axons into the contralateral optic nerve, and this defect is partially phenocopied by selective disruption of Rock signaling in RGC axons. These data implicate Rock downstream of a molecular mechanism that is critical for RGC axons to be able to ignore a domain, the optic nerve, which they previously found attractive.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Axon guidance; Growth cone; Optic nerve; Rock; Visual system; Xenopus

Mesh:

Substances:

Year:  2015        PMID: 26455469     DOI: 10.1016/j.mcn.2015.10.001

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  1 in total

1.  A Ser75-to-Asp phospho-mimicking mutation in Src accelerates ageing-related loss of retinal ganglion cells in mice.

Authors:  Kenji Kashiwagi; Sadahiro Ito; Shuichiro Maeda; Goro Kato
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.